Oramed Pharmaceuticals Inc. SEC filings ORMP
Oramed Pharmaceuticals Inc. has 941 filings in SEC EDGAR's recent list, going back to Nov 29, 2002. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Aug 3, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Jul 16, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Jul 16, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Jun 20, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | May 31, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 6, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Nov 24, 2021 | Aug 31, 2021 |
| 10-K | Annual report | Nov 24, 2020 | Aug 31, 2020 |
| 10-K | Annual report | Nov 27, 2019 | Aug 31, 2019 |
| 10-K | Annual report | Nov 28, 2018 | Aug 31, 2018 |
| 10-K | Annual report | Nov 29, 2017 | Aug 31, 2017 |
| 10-K | Annual report | Nov 25, 2016 | Aug 31, 2016 |
| 10-K | Annual report | Nov 25, 2015 | Aug 31, 2015 |
| ARS | Annual report to shareholders | Jul 8, 2015 | Aug 31, 2014 |
| 10-K | Annual report | Nov 14, 2014 | Aug 31, 2014 |
| ARS | Annual report to shareholders | Jun 20, 2014 | Aug 31, 2013 |
| 10-K | Annual report | Nov 27, 2013 | Aug 31, 2013 |
| 10-K/A | Amended annual report | Dec 21, 2012 | Aug 31, 2012 |
| 10-K | Annual report | Dec 12, 2012 | Aug 31, 2012 |
| ARS | Annual report to shareholders | Jul 5, 2012 | Aug 31, 2011 |
| 10-K | Annual report | Nov 29, 2011 | Aug 31, 2011 |
| 10-K | Annual report | Nov 29, 2010 | Aug 31, 2010 |
| 10-K | Annual report | Nov 25, 2009 | Aug 31, 2009 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORMP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1176309
- Former names
- Integrated Security Technologies, Inc. (until Apr 10, 2006); IGUANA VENTURES LTD (until Jun 10, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.